Clinical trial
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent…
NCT00322920 · University of Alabama at Birmingham, Other · Terminated
Key facts
| NCT number | NCT00322920 |
|---|---|
| Title | Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer |
| Official title | A Phase I Study of Weekly Topotecan With Cisplatin for the Management of Advanced Stage or Recurrent Carcinoma of the Cervix |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervix Cancer |
| Intervention type | Drug |
| Interventions | Topotecan, Cisplatin |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| First posted | May 8, 2006 |
| Last update posted | Feb 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: